MOLN Stock Analysis: Buy, Sell, or Hold?
MOLN - Molecular Partners AG American Depositary Shares
$4.12
0.19 (4.83%)
▲
5d:
+3.78%
30d:
+8.42%
90d:
-7.62%
BUY
MODERATE Confidence
Analysis Updated: Jul 29, 2026 12:00 AM ET
Earnings: Aug 24, 2026
19d
Get Alerted When MOLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: MOLN shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: MOLN shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: MOLN is currently trading at $4.12, which is considered extended relative to its 30-day fair value range of $3.89 to $4.06. From a valuation perspective, the stock is trading at a discount (Forward PE: -19.7) compared to its historical average (31.9). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MOLN is in a downtrend. Immediate support is located at $3.83, while resistance sits at $4.25. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.12 (+169.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MOLN is in a downtrend. Immediate support is located at $3.83, while resistance sits at $4.25. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $11.12 (+169.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.89 -
$4.06
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 169.8% below Wall St target ($11.12)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$3.89 -
$4.06
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.83
Resistance Level
$4.25
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.68
Wall Street Target
$11.12
(+169.8%)
Revenue Growth (YoY)
-100.0%
PE vs Historical
-19.7 vs 31.9
CHEAP
Share & Embed Analysis
Last updated: August 03, 2026 9:34 PM ET
Data refreshes hourly during market hours. Next update: 10:34 PM
Data refreshes hourly during market hours. Next update: 10:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MOLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 50 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 56 HOLD |
